JP2014509595A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014509595A5 JP2014509595A5 JP2013558234A JP2013558234A JP2014509595A5 JP 2014509595 A5 JP2014509595 A5 JP 2014509595A5 JP 2013558234 A JP2013558234 A JP 2013558234A JP 2013558234 A JP2013558234 A JP 2013558234A JP 2014509595 A5 JP2014509595 A5 JP 2014509595A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- seq
- immunotherapeutic composition
- brachyury
- yeast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161453656P | 2011-03-17 | 2011-03-17 | |
| US61/453,656 | 2011-03-17 | ||
| PCT/US2012/029636 WO2012125998A1 (en) | 2011-03-17 | 2012-03-19 | Yeast-brachyury immunotherapeutic compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016249307A Division JP6309607B2 (ja) | 2011-03-17 | 2016-12-22 | 酵母−ブラキュリ免疫治療組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014509595A JP2014509595A (ja) | 2014-04-21 |
| JP2014509595A5 true JP2014509595A5 (enExample) | 2015-04-30 |
| JP6068368B2 JP6068368B2 (ja) | 2017-01-25 |
Family
ID=46831122
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013558234A Active JP6068368B2 (ja) | 2011-03-17 | 2012-03-19 | 酵母−ブラキュリ免疫治療組成物 |
| JP2016249307A Active JP6309607B2 (ja) | 2011-03-17 | 2016-12-22 | 酵母−ブラキュリ免疫治療組成物 |
| JP2018046148A Active JP6580733B2 (ja) | 2011-03-17 | 2018-03-14 | 酵母−ブラキュリ免疫治療組成物 |
| JP2019155138A Pending JP2019199484A (ja) | 2011-03-17 | 2019-08-28 | 酵母−ブラキュリ免疫治療組成物 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016249307A Active JP6309607B2 (ja) | 2011-03-17 | 2016-12-22 | 酵母−ブラキュリ免疫治療組成物 |
| JP2018046148A Active JP6580733B2 (ja) | 2011-03-17 | 2018-03-14 | 酵母−ブラキュリ免疫治療組成物 |
| JP2019155138A Pending JP2019199484A (ja) | 2011-03-17 | 2019-08-28 | 酵母−ブラキュリ免疫治療組成物 |
Country Status (19)
| Country | Link |
|---|---|
| US (5) | US9198941B2 (enExample) |
| EP (2) | EP2685995B1 (enExample) |
| JP (4) | JP6068368B2 (enExample) |
| KR (1) | KR102046449B1 (enExample) |
| CN (1) | CN103648513B (enExample) |
| AU (3) | AU2012228937B2 (enExample) |
| BR (1) | BR112013023456B1 (enExample) |
| CA (1) | CA2835475C (enExample) |
| DK (1) | DK2685995T3 (enExample) |
| ES (1) | ES2627979T3 (enExample) |
| HK (1) | HK1245649A1 (enExample) |
| HU (1) | HUE033491T2 (enExample) |
| IL (1) | IL228421B (enExample) |
| MX (1) | MX350661B (enExample) |
| PL (1) | PL2685995T3 (enExample) |
| PT (1) | PT2685995T (enExample) |
| RU (2) | RU2690180C2 (enExample) |
| SG (2) | SG193396A1 (enExample) |
| WO (1) | WO2012125998A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009006479A2 (en) | 2007-07-02 | 2009-01-08 | Etubics Corporation | Methods and compositions for producing an adenovirus vector for use with multiple vaccinations |
| EP2651439B1 (en) | 2010-12-17 | 2018-09-19 | Globeimmune, Inc. | Compositions and methods for the treatment or prevention of human adenovirus-36 infection |
| JP5745102B2 (ja) | 2011-02-12 | 2015-07-08 | グローブイミューン，インコーポレイテッド | 慢性ｂ型肝炎感染症のための酵母系免疫療法組成物 |
| SG193396A1 (en) | 2011-03-17 | 2013-10-30 | Globeimmune Inc | Yeast-brachyury immunotherapeutic compositions |
| WO2012174220A1 (en) | 2011-06-14 | 2012-12-20 | Globeimmune, Inc. | Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection |
| RU2642300C2 (ru) | 2011-08-17 | 2018-01-24 | Глоубиммьюн, Инк. | Иммунотерапевтические композиции на основе дрожжей-muc1 и способы их применения |
| SG11201408652SA (en) | 2012-06-26 | 2015-01-29 | Biodesix Inc | Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immune response generating therapies |
| US9605276B2 (en) | 2012-08-24 | 2017-03-28 | Etubics Corporation | Replication defective adenovirus vector in vaccination |
| ES2752190T3 (es) * | 2012-09-14 | 2020-04-03 | Us Health | Proteína Brachyury, vectores adenovirales que codifican proteína Brachyury y su uso |
| KR20150132867A (ko) * | 2013-03-19 | 2015-11-26 | 글로브이뮨 | 척색종에 대한 효모-기반의 면역치료 |
| TWI626948B (zh) | 2013-03-26 | 2018-06-21 | 環球免疫公司 | 治療或預防人類免疫缺乏病毒感染之組合物及方法 |
| US9725494B2 (en) * | 2013-05-17 | 2017-08-08 | United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Soluble CD27 (sCD27) and the use thereof |
| WO2015031778A2 (en) | 2013-08-30 | 2015-03-05 | Globeimmune, Inc. | Compositions and methods for the treatment or prevention of tuberculosis |
| US10799567B2 (en) | 2014-04-11 | 2020-10-13 | Globeimmune, Inc. | Yeast-based immunotherapy and type I interferon sensitivity |
| AU2016205215B2 (en) | 2015-01-09 | 2021-03-11 | Etubics Corporation | Methods and compositions for combination immunotherapy |
| US11149087B2 (en) | 2015-04-20 | 2021-10-19 | Etubics Corporation | Methods and compositions for combination immunotherapy |
| EP4137150A1 (en) | 2015-08-03 | 2023-02-22 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use |
| JP6789283B2 (ja) * | 2015-08-03 | 2020-11-25 | グローブイミューン，インコーポレイテッド | 改変酵母−ブラキュリー免疫療法組成物 |
| JP2019513021A (ja) | 2016-03-24 | 2019-05-23 | ナントセル，インコーポレイテッド | ネオエピトープ提示のための配列の配置および配列 |
| SG11201810631SA (en) * | 2016-06-03 | 2018-12-28 | Etubics Corp | Compositions and methods for tumor vaccination using prostate cancer-associated antigens |
| EP3541400B1 (en) * | 2016-11-18 | 2025-05-14 | Sanford Burnham Prebys Medical Discovery Institute | Gut microbiota and treatment of cancer |
| CN116983395A (zh) | 2017-04-24 | 2023-11-03 | 河谷细胞有限公司 | 靶向性新表位载体及其方法 |
| KR20220068272A (ko) * | 2017-08-15 | 2022-05-25 | 난트셀, 인크. | Hank 세툭시맙 조합 및 방법 |
| CN112543640B (zh) | 2018-05-15 | 2025-02-14 | 全球免疫公司 | 用于诱导细胞免疫应答的重组酵母裂解物 |
| US11857620B2 (en) | 2020-03-11 | 2024-01-02 | Immunitybio, Inc. | Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus |
| US12285480B2 (en) | 2020-03-11 | 2025-04-29 | Nantcell, Inc. | Method of inducing immunity against SARS-CoV-2 using spike and nucleocapsid-ETSD immunogens delivered by RNA and replication-defective adenoviruses |
| US20210284716A1 (en) | 2020-03-11 | 2021-09-16 | Immunitybio, Inc. | ACE2-Fc Trap |
| US12245355B2 (en) | 2021-02-19 | 2025-03-04 | Mevion Medical Systems, Inc. | Gantry for a particle therapy system |
| US12558408B2 (en) * | 2022-03-08 | 2026-02-24 | Immunitybio, Inc. | Intratumorally injected yeast vaccine |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1036329A (en) | 1908-11-19 | 1912-08-20 | Edison Inc Thomas A | Phonograph-reproducer. |
| FR2486400B1 (fr) | 1980-07-09 | 1986-05-30 | Univablot | Medicaments a base de levures ou de leurs extraits insolubles |
| NZ199722A (en) | 1981-02-25 | 1985-12-13 | Genentech Inc | Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain |
| US4775622A (en) | 1982-03-08 | 1988-10-04 | Genentech, Inc. | Expression, processing and secretion of heterologous protein by yeast |
| US5310654A (en) | 1985-07-31 | 1994-05-10 | The Board Of Trustees Of The Leland Stanford Junior University | Method for determining virulence of Yersinia |
| US5234830A (en) | 1988-02-03 | 1993-08-10 | Suntory Limited | DNA encoding a KEX2 endoprotease without a C-terminal hydrophobic region |
| IL95019A0 (en) | 1989-08-09 | 1991-06-10 | Mycogen Corp | Process for encapsulation of biologicals |
| US5830463A (en) | 1993-07-07 | 1998-11-03 | University Technology Corporation | Yeast-based delivery vehicles |
| US5413914A (en) | 1993-07-07 | 1995-05-09 | The Regents Of The University Of Colorado | Yeast assay to identify inhibitors of dibasic amino acid processing endoproteases |
| US5858378A (en) | 1996-05-02 | 1999-01-12 | Galagen, Inc. | Pharmaceutical composition comprising cryptosporidium parvum oocysts antigen and whole cell candida species antigen |
| US20020044948A1 (en) | 2000-03-15 | 2002-04-18 | Samir Khleif | Methods and compositions for co-stimulation of immunological responses to peptide antigens |
| EP1272213B1 (en) | 2000-04-06 | 2006-03-08 | SEER Pharmaceuticals, LLC. | Microbial delivery system |
| AU2002225681A1 (en) | 2000-11-15 | 2002-05-27 | Globe Immune, Inc. | Yeast-dentritic cell vaccines and uses thereof |
| KR101241272B1 (ko) | 2002-12-16 | 2013-03-15 | 더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 | 면역 요법으로서의 효모계 백신 |
| US7439042B2 (en) | 2002-12-16 | 2008-10-21 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis C infection |
| US20100034840A1 (en) * | 2005-07-11 | 2010-02-11 | David Apelian | Compositions and methods for eliciting an immune response to escape mutants of targeted therapies |
| US20070172503A1 (en) | 2005-12-13 | 2007-07-26 | Mycologics,Inc. | Compositions and Methods to Elicit Immune Responses Against Pathogenic Organisms Using Yeast Based Vaccines |
| KR20140029551A (ko) * | 2006-02-02 | 2014-03-10 | 글로브이뮨 | 면역 반응 유도를 위한 효모-기반 백신 |
| EP2004666B1 (en) * | 2006-03-27 | 2014-09-03 | Globeimmune, Inc. | Ras mutation and compositions and methods related thereto |
| EP2121013B1 (en) | 2007-02-02 | 2014-10-15 | Globeimmune, Inc. | Methods for producing yeast-based vaccines |
| WO2008106551A2 (en) * | 2007-02-28 | 2008-09-04 | The Govt. Of The U.S.A. As Represented By The Secretary Of The Dept. Of Health & Human Serv. | Brachyury polypeptides and methods for use |
| CA2681246A1 (en) | 2007-03-19 | 2008-09-25 | Globeimmune, Inc. | Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancer |
| WO2009042645A2 (en) | 2007-09-24 | 2009-04-02 | President And Fellows Of Harvard College | The use of mice predisposed to develop ulcerative colitis and colon cancer to develop metabolic profiles associated with same |
| US8728489B2 (en) | 2008-09-19 | 2014-05-20 | Globeimmune, Inc. | Immunotherapy for chronic hepatitis C virus infection |
| WO2010065626A1 (en) | 2008-12-02 | 2010-06-10 | Globeimmune, Inc. | Genotyping tools, methods and kits |
| EP3320915A1 (en) * | 2009-04-17 | 2018-05-16 | Globeimmune, Inc. | Combination immunotherapy compositions against cancer and methods |
| AU2010291985B2 (en) | 2009-09-14 | 2016-05-05 | The Regents Of The University Of Colorado | Modulation of yeast-based immunotherapy products and responses |
| WO2011115914A1 (en) | 2010-03-14 | 2011-09-22 | Globeimmune, Inc. | Pharmacogenomic and response-guided treatment of infectious disease using yeast-based immunotherapy |
| WO2012019127A2 (en) * | 2010-08-05 | 2012-02-09 | The Regents Of The University Of Colorado | Combination yeast-based immunotherapy and arginine therapy for the treatment of myeloid-derived supressor cell-associated diseases |
| EP2651439B1 (en) | 2010-12-17 | 2018-09-19 | Globeimmune, Inc. | Compositions and methods for the treatment or prevention of human adenovirus-36 infection |
| JP5745102B2 (ja) | 2011-02-12 | 2015-07-08 | グローブイミューン，インコーポレイテッド | 慢性ｂ型肝炎感染症のための酵母系免疫療法組成物 |
| SG193396A1 (en) | 2011-03-17 | 2013-10-30 | Globeimmune Inc | Yeast-brachyury immunotherapeutic compositions |
| WO2012174220A1 (en) | 2011-06-14 | 2012-12-20 | Globeimmune, Inc. | Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection |
| RU2642300C2 (ru) | 2011-08-17 | 2018-01-24 | Глоубиммьюн, Инк. | Иммунотерапевтические композиции на основе дрожжей-muc1 и способы их применения |
-
2012
- 2012-03-19 SG SG2013068176A patent/SG193396A1/en unknown
- 2012-03-19 PL PL12757534T patent/PL2685995T3/pl unknown
- 2012-03-19 HU HUE12757534A patent/HUE033491T2/en unknown
- 2012-03-19 MX MX2013010475A patent/MX350661B/es active IP Right Grant
- 2012-03-19 JP JP2013558234A patent/JP6068368B2/ja active Active
- 2012-03-19 PT PT127575348T patent/PT2685995T/pt unknown
- 2012-03-19 AU AU2012228937A patent/AU2012228937B2/en active Active
- 2012-03-19 ES ES12757534.8T patent/ES2627979T3/es active Active
- 2012-03-19 DK DK12757534.8T patent/DK2685995T3/en active
- 2012-03-19 RU RU2017116350A patent/RU2690180C2/ru active
- 2012-03-19 CN CN201280023412.6A patent/CN103648513B/zh active Active
- 2012-03-19 RU RU2013146324A patent/RU2619850C2/ru active IP Right Revival
- 2012-03-19 SG SG10201601913RA patent/SG10201601913RA/en unknown
- 2012-03-19 KR KR1020137027169A patent/KR102046449B1/ko active Active
- 2012-03-19 WO PCT/US2012/029636 patent/WO2012125998A1/en not_active Ceased
- 2012-03-19 CA CA2835475A patent/CA2835475C/en active Active
- 2012-03-19 EP EP12757534.8A patent/EP2685995B1/en active Active
- 2012-03-19 BR BR112013023456-3A patent/BR112013023456B1/pt active IP Right Grant
- 2012-03-19 EP EP17154014.9A patent/EP3238731B1/en active Active
-
2013
- 2013-03-14 US US13/803,719 patent/US9198941B2/en active Active
- 2013-09-12 IL IL228421A patent/IL228421B/en active IP Right Grant
-
2015
- 2015-10-29 US US14/926,372 patent/US9623097B2/en active Active
-
2016
- 2016-12-22 JP JP2016249307A patent/JP6309607B2/ja active Active
-
2017
- 2017-02-02 AU AU2017200715A patent/AU2017200715B2/en active Active
- 2017-03-09 US US15/454,176 patent/US10363294B2/en active Active
-
2018
- 2018-03-14 JP JP2018046148A patent/JP6580733B2/ja active Active
- 2018-04-19 HK HK18105126.6A patent/HK1245649A1/en unknown
- 2018-04-30 AU AU2018202972A patent/AU2018202972B2/en active Active
-
2019
- 2019-04-19 US US16/389,235 patent/US11944673B2/en active Active
- 2019-08-28 JP JP2019155138A patent/JP2019199484A/ja active Pending
-
2020
- 2020-12-21 US US17/129,633 patent/US11938175B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2013146324A (ru) | Иммунотерапевтические композиции на основе дрожжей с brachyury | |
| Zhang et al. | Personalized cancer vaccines: Targeting the cancer mutanome | |
| Vacchelli et al. | Trial watch: Peptide vaccines in cancer therapy | |
| JP2012524075A5 (enExample) | ||
| Kumai et al. | Cancer immunotherapy: moving forward with peptide T cell vaccines | |
| RU2014109741A (ru) | Иммунотерапевтические композиции на основе дрожжей-muc1 и способы их применения | |
| IL294183B2 (en) | shared neoantigens | |
| EP3545965A3 (en) | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers | |
| CN110621334A (zh) | 个性化免疫原性肽鉴定平台 | |
| JP2018501243A (ja) | 組み換え型リステリア菌株を用いた併用療法 | |
| JP2019512020A5 (enExample) | ||
| Baratta | Glioblastoma is ‘hot’for personalized vaccines | |
| JP2018522041A5 (enExample) | ||
| WO2021094562A3 (en) | Antigenic peptides for prevention and treatment of b-cell malignancy | |
| JP2020511139A5 (enExample) | ||
| RU2019132253A (ru) | Новая днк-вакцина, нацеленная на pd-l1, для иммунотерапии рака | |
| Chen et al. | The current therapeutic cancer vaccines landscape in non‐small cell lung cancer | |
| Izzi et al. | Poxvirus-based vaccines for cancer immunotherapy: New insights from combined cytokines/co-stimulatory molecules delivery and “uncommon” strains | |
| Suzuki et al. | Current status of vaccine immunotherapy for gastrointestinal cancers | |
| JP2020507332A5 (enExample) | ||
| Horwich et al. | 1000 Organ conservation in bladder cancer | |
| Chu et al. | Therapeutic cancer vaccines: navigating clinical translation and multimodal synergy | |
| Mohapatra et al. | Cancer vaccines: types, mechanisms, and recent developments | |
| Sasada et al. | A patient with stage IV gastric cancer who acquired complete remission after undergoing multi-peptide dendritic cell immunotherapy in combination with standard therapies | |
| Alanazi et al. | Advances in Prostate Cancer Immunotherapy: Current Options and Emerging Novel Approaches |